Short reportPrevalence of resistance to antiseptics and mupirocin among invasive coagulase-negative staphylococci from very preterm neonates in NICU: the creeping threat?
Introduction
In neonatal intensive care units (NICU), catheter-associated bloodstream infections (CABSI) due to coagulase-negative staphylococci (CNS) are the main healthcare-associated infections (HAI), occurring in 11% of patients. HAI increase morbidity, mortality and risk of long-term disabilities.1 Preventive measures include the use of chlorhexidine (CHX) for skin antisepsis, gauze dressing and catheter injection hub-site disinfection.1 Combination therapy with CHX skin disinfection and mupirocin nasal decolonization can be effective in managing outbreaks of Staphylococcus aureus infections.2
Unfortunately, the use of topical agents can select resistant strains of staphylococci. MupA is the major resistance gene responsible for high-level mupirocin resistance.3 Quaternary ammonium compound (QAC)-resistant determinants, encoded by qac family genes, are multi-drug efflux pumps that decrease bacterial susceptibility to cationic antiseptic agents.4 Mainly located on mobile genetic elements as plasmids, these genes could be transferred between staphylococcal species.4
Beyond failure of CABSI preventive strategies, CNS that are resistant to topical agents could act as a reservoir of mupA and qac genes that could be transferred to S. aureus.3, 4 This paper reports a phenotypic and molecular study evaluating the prevalence of antiseptic- and mupirocin-resistant strains among CNS responsible for CABSI in a French referral NICU.
Section snippets
Methods
This study was performed in a level 3, 28-bedded NICU at the university-affiliated Antoine Béclère Hospital (Assistance Publique–Hôpitaux de Paris network). During the study period, 1799 neonates were admitted to the NICU (total 21,796 patient-days).
All non-duplicate CNS from clinically relevant CABSI diagnosed among preterm neonates (<32 completed weeks of gestation) between January 2009 and September 2011 were included. CABSI was defined according to international consensus criteria: one or
Results
Over the study period, 51 strains were collected from extremely preterm (67.4%) or very preterm (32.6%) neonates (all weighing <1500 g). The species distribution was: S. epidermidis (N = 25), S. capitis (N = 18), Staphylococcus haemolyticus (N = 2) and other species (N = 6).
All but one strain was resistant to meticillin, and 88% and 30% were resistant to gentamicin and ofloxacin, respectively. All strains were susceptible to vancomycin, and all but two strains were susceptible to teicoplanin.
Discussion
The burden of HAI in NICU has led physicians to use preventive strategies including antiseptics and topical antimicrobial compounds. The present study found a high prevalence of phenotypic and genotypic antiseptic and mupirocin resistance among a sample of clinically relevant CNS isolated from preterm neonates. Reports concerning mupirocin and antiseptic susceptibility of CNS are scarce, and to the best of the authors' knowledge, this work provides the first data from an NICU. In the present
Acknowledgments
The authors wish to thank the staff from the NICU and the pharmacy.
References (10)
- et al.
Alcoholic povidone-iodine or chlorhexidine-based antiseptic for the prevention of central venous catheter-related infections: in-use comparison
J Infect Public Health
(2012) - et al.
Strategies for prevention of health care-associated infections in the NICU
Pediatrics
(2012) - et al.
Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study
Infect Control Hosp Epidemiol
(2010) - et al.
Emergence of high level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use
J Clin Microbiol
(2012) - et al.
Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?
J Antimicrob Chemother
(2012)